Healing biologicals from Antarctica: Eczema study finds 91% participants found relief using Arctiva formulation
03 May 2023 --- An independent consumer study has affirmed the efficacy of Arctiva’s eczema cream, finding symptom reduction in 91% of participants. The clean-label steroid-free skin care brand launched its eczema and psoriasis treatments last month, harnessing active ingredients with proprietary Hydrosurf glycolipid technology.
Arctiva Eczema Cream is reportedly the only product line on the market with Hydrosurf glycolipid technology – a blend of fermented ingredients originating in Antarctica’s glacial lakes. It is combined with other natural, cruelty-free ingredients, including FDA-approved 1% colloidal oatmeal as an active ingredient, glycolic acid, key vitamins, essential oils and botanicals.
The consumer study found that within seven days of usage, participants experienced significant relief of itching, redness and flaking. Additionally, symptoms continued to improve for over 90% of the patients throughout the 28-day study with consistent use of Arctiva Eczema Cream.
According to Arctiva, after the first day, 73% of the panelists reported skin soothing and hydration, while in the first seven days, four in five participants saw reduced flaking and itching.
“While the results speak for themselves, the consumer panel confirms what we expected. Arctiva Eczema Cream can make a significant difference in the symptoms and the lives of the 30 million Americans suffering from eczema and other forms of dermatitis,” says Vic Peroni, chief operating officer at Arctiva Wellness.
“Our formulation team researched high-quality, eczema-focused ingredients to provide a much-needed solution that doesn’t require a prescription. We wanted a clean-label, steroid-free skincare product that delivers medical-grade results.”
In the first seven days four in five participants reported reduced flaking and itching.Antarctic actives
Activa’s proprietary ingredient Hydrosurf is a “breakthrough” blend of glycolipids that boost absorption, improve hydration, stimulate exfoliation and help the body respond to irritation.
“Our breakthrough blend of these ingredients dates back to the discovery of microorganisms found in nature, such as glacial lakes in Antarctica,” the skin care brand states.
“Hydrosurf glycolipids boost the absorption of water and essential ingredients into previously unreachable levels of the skin to get to the source of symptoms. It increases water mobility, which means it helps water penetrate oils and lipids within the skin,” it continues.
Furthermore, Arctiva explains that skin conditions can cause a buildup of dead or damaged skin cells, preventing new skin cells from forming. Hydrosurf stimulates skin activity and exfoliation, allowing new skin cells to replace the damaged or dead cells and promoting healthier-looking skin.
Arctiva Eczema Cream combines the benefits of Hydrosurf with vitamins, essential oils and botanicals: vitamin A, vitamin B3 (niacinamide), vitamin C, vitamin E, jojoba oil, lonicera japonica extract, caprifolium flower extracts and glycolic acid.
The ingredients collectively offer a variety of antioxidant and healing properties supporting skin health.
Peroni says: “The use of clinically proven active ingredients with our proprietary Hydrosurf glycolipid technology and other key ingredients is a uniquely synergistic combination that’s never been done before in formulations for these skin conditions [eczema and psoriasis].”
Maintaining skin health
The skin barrier is essential to skin care and goes beyond beauty into skin health. We spoke to Montagne Jeunesse, International Flavors & Fragrances and Seqens on developments, top ingredients and the role of the skin’s microbiome in boosting the functioning of the skin barrier against pollution, dryness and irritants.
“A disrupted barrier function leads to increased transepidermal water loss and to more sensitive skin that may even cause major skin disorders such as atopic dermatitis,” Aïna Queiroz, head of cosmetic Innovation and Scientific Communication at Seqens, highlighted.
Last September, research funded by Lundbeck Foundation and led by scientists at Bispebjerg Hospital, Copenhagen, found that analyzing immune biomarkers via a painless tape could predict the chances of newborns developing pediatric atopic eczema, commonly experienced by babies.
“Our findings of predictive skin biomarkers collected at two months of age will help identify children at highest risk of atopic eczema using a non-invasive and painless method, so future preventive strategies can target these children only and prevent cases of this common disease,” Dr. Anne-Sofie Halling, first author and co-researcher at the Bispebjerg Hospital, University of Copenhagen, told PersonalCareInsights.
Edited by Radhika Sikaria
